GALT Competitors & Alternatives
Compare Galectin Therapeutics Inc with similar stocks in the same industry
Biotechnology
GALT
Main Stock$3.03
Tradestie Score
52
Market Cap
$267.77M
Analyst Upside
+263.0%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$32.87
|
$256.54M | - | 58 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$11.22
|
$211.22M | - | 48 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.53
|
$202.58M | - | 57 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.87
|
$199.71M | - | 46 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.61
|
$180.53M | - | 52 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.05
|
$170.45M | - | 56 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.32
|
$158.43M | - | 48 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.60
|
$154.27M | - | 56 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.81
|
$133.50M | - | 56 | Compare |
More GALT Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry